SG11202107481TA - Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound - Google Patents
Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compoundInfo
- Publication number
- SG11202107481TA SG11202107481TA SG11202107481TA SG11202107481TA SG11202107481TA SG 11202107481T A SG11202107481T A SG 11202107481TA SG 11202107481T A SG11202107481T A SG 11202107481TA SG 11202107481T A SG11202107481T A SG 11202107481TA SG 11202107481T A SG11202107481T A SG 11202107481TA
- Authority
- SG
- Singapore
- Prior art keywords
- quinoxaline
- substituted
- polymorphic forms
- piperidine compound
- type bridged
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962799710P | 2019-01-31 | 2019-01-31 | |
| PCT/IB2020/050741 WO2020157691A1 (en) | 2019-01-31 | 2020-01-30 | Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202107481TA true SG11202107481TA (en) | 2021-08-30 |
Family
ID=69528888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107481TA SG11202107481TA (en) | 2019-01-31 | 2020-01-30 | Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220098186A1 (ja) |
| EP (1) | EP3917621A1 (ja) |
| JP (2) | JP2022519231A (ja) |
| KR (1) | KR102659846B1 (ja) |
| CN (1) | CN113301957A (ja) |
| AU (2) | AU2020213989B2 (ja) |
| BR (1) | BR112021010184A2 (ja) |
| CA (1) | CA3127469A1 (ja) |
| IL (1) | IL284564A (ja) |
| MX (1) | MX2021008039A (ja) |
| SG (1) | SG11202107481TA (ja) |
| UA (1) | UA126880C2 (ja) |
| WO (1) | WO2020157691A1 (ja) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| US6572891B1 (en) | 1999-10-23 | 2003-06-03 | Alkaloid Ad | Sublingual oral dosage form |
| CN1819819B (zh) | 2003-05-07 | 2011-03-09 | 株式会社三养社 | 用于制备速熔片的高度可塑性颗粒 |
| ES2536922T3 (es) | 2006-09-15 | 2015-05-29 | Echo Pharmaceuticals B.V. | Unidad de dosificación para administración sublingual, bucal u oral de sustancias farmacéuticamente activas insolubles en agua |
| BRPI0815327A2 (pt) | 2007-08-31 | 2015-12-15 | Purdue Pharma Lp | "compostos de piperidina do tipo quinoxalina substituída e os usos destes" |
| CN104127368A (zh) | 2008-03-11 | 2014-11-05 | 武田药品工业株式会社 | 口腔崩解固体制剂 |
| PE20140102A1 (es) | 2008-07-21 | 2014-02-06 | Purdue Pharma Lp | Compuestos de piperidina puenteada tipo quinoxalina sustituida con actividad sobre el receptor orl-1 |
| US9085561B2 (en) * | 2012-07-30 | 2015-07-21 | Purdue Pharma L.P. | Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators |
| US9040533B2 (en) * | 2012-12-27 | 2015-05-26 | Purdue Pharma L.P. | Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators |
| JOP20190008A1 (ar) * | 2016-07-26 | 2019-01-24 | Purdue Pharma Lp | علاج ومنع اضطرابات النوم |
-
2020
- 2020-01-30 CN CN202080007741.6A patent/CN113301957A/zh active Pending
- 2020-01-30 KR KR1020217016694A patent/KR102659846B1/ko active IP Right Grant
- 2020-01-30 WO PCT/IB2020/050741 patent/WO2020157691A1/en active Application Filing
- 2020-01-30 MX MX2021008039A patent/MX2021008039A/es unknown
- 2020-01-30 JP JP2021544362A patent/JP2022519231A/ja active Pending
- 2020-01-30 UA UAA202103724A patent/UA126880C2/uk unknown
- 2020-01-30 SG SG11202107481TA patent/SG11202107481TA/en unknown
- 2020-01-30 AU AU2020213989A patent/AU2020213989B2/en active Active
- 2020-01-30 CA CA3127469A patent/CA3127469A1/en active Pending
- 2020-01-30 BR BR112021010184-5A patent/BR112021010184A2/pt unknown
- 2020-01-30 US US17/310,380 patent/US20220098186A1/en active Pending
- 2020-01-30 EP EP20704594.9A patent/EP3917621A1/en active Pending
-
2021
- 2021-07-01 IL IL284564A patent/IL284564A/en unknown
-
2023
- 2023-05-29 AU AU2023203345A patent/AU2023203345A1/en active Pending
- 2023-06-20 JP JP2023100897A patent/JP2023116756A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3917621A1 (en) | 2021-12-08 |
| AU2020213989A1 (en) | 2021-06-17 |
| AU2023203345A1 (en) | 2023-06-22 |
| JP2023116756A (ja) | 2023-08-22 |
| WO2020157691A1 (en) | 2020-08-06 |
| AU2020213989B2 (en) | 2023-06-15 |
| KR20210087493A (ko) | 2021-07-12 |
| IL284564A (en) | 2021-08-31 |
| JP2022519231A (ja) | 2022-03-22 |
| CA3127469A1 (en) | 2020-08-06 |
| BR112021010184A2 (pt) | 2021-08-17 |
| US20220098186A1 (en) | 2022-03-31 |
| UA126880C2 (uk) | 2023-02-15 |
| MX2021008039A (es) | 2021-08-05 |
| KR102659846B1 (ko) | 2024-04-24 |
| CN113301957A (zh) | 2021-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202207543B (en) | Pyridazinyl-thiazolecarboxamide compound | |
| GB202019810D0 (en) | Compound | |
| EP3619208C0 (en) | CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND | |
| IL289929A (en) | Crystal forms of cd73 inhibitor | |
| IL304845A (en) | Pyrimidopyran compounds | |
| GB202011800D0 (en) | Compound | |
| IL279853A (en) | Polymorphic forms of RAD 1901-2HCL | |
| IL284226A (en) | Crystal structures of a TGFB inhibitor | |
| GB202013721D0 (en) | New compounds | |
| IL284662A (en) | A new compound derived from cellulose | |
| IL284564A (en) | Polymorphic forms of a modified quinoline-type bridged piperidine compound | |
| ZA202007034B (en) | The crystalline forms of a compound | |
| GB202014070D0 (en) | Polymorph | |
| GB201912411D0 (en) | Crystalline forms of ivosidenib | |
| GB201910664D0 (en) | Novel forms of compound | |
| GB202208329D0 (en) | Compound | |
| GB202204673D0 (en) | Compound | |
| GB202117834D0 (en) | Compound | |
| GB202117836D0 (en) | Compound | |
| EP4209555A4 (en) | CONNECTION | |
| GB202018245D0 (en) | Compound | |
| GB202011787D0 (en) | Compound | |
| GB202010626D0 (en) | Compound | |
| GB202009074D0 (en) | Compound | |
| GB202109946D0 (en) | New compounds |